364 related articles for article (PubMed ID: 27070462)
21. Che-1 gene silencing induces osteosarcoma cell apoptosis by inhibiting mutant p53 expression.
Liu M; Wang D; Li N
Biochem Biophys Res Commun; 2016 Apr; 473(1):168-173. PubMed ID: 27012205
[TBL] [Abstract][Full Text] [Related]
22. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
[No Abstract] [Full Text] [Related]
23. MicroRNA‑20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression.
Zhuo W; Ge W; Meng G; Jia S; Zhou X; Liu J
Mol Med Rep; 2015 Oct; 12(4):4989-94. PubMed ID: 26238942
[TBL] [Abstract][Full Text] [Related]
24. Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target.
Liu Y; Luo G; He D
Bioengineered; 2019 Dec; 10(1):133-141. PubMed ID: 31055998
[TBL] [Abstract][Full Text] [Related]
25. Second messenger signaling in the regulation of cytosolic pH and DNA synthesis by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: role of Na+/H+ exchange.
Sugimoto T; Kano J; Fukase M; Fujita T
J Cell Physiol; 1992 Jul; 152(1):28-34. PubMed ID: 1320038
[TBL] [Abstract][Full Text] [Related]
26. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling.
Sui Y; Han Y; Zhao X; Li D; Li G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):36-42. PubMed ID: 30454890
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
[TBL] [Abstract][Full Text] [Related]
30. siRNA targeting TCTP suppresses osteosarcoma cell growth and induces apoptosis in vitro and in vivo.
Shen JH; Qu CB; Chu HK; Cui MY; Wang YL; Sun YX; Song YD; Li G; Shi FJ
Biotechnol Appl Biochem; 2016; 63(1):5-14. PubMed ID: 25522670
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
Wang J; Cao L; Wu J; Wang Q
Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
[TBL] [Abstract][Full Text] [Related]
32. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review).
Nikitovic D; Kavasi RM; Berdiaki A; Papachristou DJ; Tsiaoussis J; Spandidos DA; Tsatsakis AM; Tzanakakis GN
Oncol Rep; 2016 Oct; 36(4):1787-92. PubMed ID: 27499459
[TBL] [Abstract][Full Text] [Related]
34. DNA damage checkpoint pathway modulates the regulation of skeletal growth and osteoblastic bone formation by parathyroid hormone-related peptide.
Zhang Y; Chen G; Gu Z; Sun H; Karaplis A; Goltzman D; Miao D
Int J Biol Sci; 2018; 14(5):508-517. PubMed ID: 29805302
[TBL] [Abstract][Full Text] [Related]
35. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
36. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells.
Park HJ; Baek K; Baek JH; Kim HR
J Cell Physiol; 2015 Mar; 230(3):667-79. PubMed ID: 25187507
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
[TBL] [Abstract][Full Text] [Related]
38. Notch activation as a driver of osteogenic sarcoma.
Tao J; Jiang MM; Jiang L; Salvo JS; Zeng HC; Dawson B; Bertin TK; Rao PH; Chen R; Donehower LA; Gannon F; Lee BH
Cancer Cell; 2014 Sep; 26(3):390-401. PubMed ID: 25203324
[TBL] [Abstract][Full Text] [Related]
39. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
